These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37397643)
21. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180 [TBL] [Abstract][Full Text] [Related]
22. [Portal vein flow rate used as a early predictor of portal vein thrombosis after periesophagastric devascularization]. Zhang Y; Wen TF; Chen ZY; Yan LN; Liang GL; Li G; Zhang XH; Ran S; Liao ZX Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(11):825-8. PubMed ID: 19961011 [TBL] [Abstract][Full Text] [Related]
23. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe. Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107 [TBL] [Abstract][Full Text] [Related]
24. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors. Chen H; Trilok G; Wang F; Qi X; Xiao J; Yang C Indian J Med Res; 2014 Feb; 139(2):260-6. PubMed ID: 24718401 [TBL] [Abstract][Full Text] [Related]
25. Portal vein thrombosis in liver cirrhosis. Kinjo N; Kawanaka H; Akahoshi T; Matsumoto Y; Kamori M; Nagao Y; Hashimoto N; Uehara H; Tomikawa M; Shirabe K; Maehara Y World J Hepatol; 2014 Feb; 6(2):64-71. PubMed ID: 24575165 [TBL] [Abstract][Full Text] [Related]
26. Management of portal vein thrombosis in liver cirrhosis. Qi X; Han G; Fan D Nat Rev Gastroenterol Hepatol; 2014 Jul; 11(7):435-46. PubMed ID: 24686266 [TBL] [Abstract][Full Text] [Related]
27. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study. Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175 [TBL] [Abstract][Full Text] [Related]
28. What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective. Ponziani FR; Zocco MA; Garcovich M; D'Aversa F; Roccarina D; Gasbarrini A World J Gastroenterol; 2012 Sep; 18(36):5014-20. PubMed ID: 23049208 [TBL] [Abstract][Full Text] [Related]
29. The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B. Cui S; Fu Z; Feng Y; Xie X; Ma X; Liu T; Wang L; Wu H; Zhu Q Thromb Res; 2018 Jan; 161():7-11. PubMed ID: 29178991 [TBL] [Abstract][Full Text] [Related]
30. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients. Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181 [TBL] [Abstract][Full Text] [Related]
31. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors]. Lin GS; Xu Q; Zhao SY; Zhang YX Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429 [No Abstract] [Full Text] [Related]
32. Portal vein thrombosis in cirrhosis. Raja K; Jacob M; Asthana S J Clin Exp Hepatol; 2014 Dec; 4(4):320-31. PubMed ID: 25755579 [TBL] [Abstract][Full Text] [Related]